Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Deborah Gill from the Radcliffe Department of Medicine and Dr Luke Jostins-Dean from the Kennedy Institute at the University of Oxford swapped lab coats for legislation at the House of Commons for a week in Westminster. The week (26 - 30 November) is part of a unique pairing scheme run by the Royal Society – the UK’s national academy of science, with support from the Government Science & Engineering (GSE) profession.  

During her visit, Deborah, who is a Professor of Gene Medicine, and Co-Director of the Gene Medicine Research Group, shadowed Tony Whitney, senior policy advisor for Public Engagement with Science for the Department of Business, Innovation and Strategy. Dr Jostins-Dean shadowed local MP for Oxford East, Annaliese Dodds.

 As well as attending seminars and panel discussions about how evidence is used in policy making, the two researchers attended a mock Select Committee.

The visit provided the Oxford academics with a behind the scenes insight into how policy is formed and how their research can be used to make evidence-based decisions. It also gave the politicians the opportunity to investigate the science behind their decisions and improve their access to scientific evidence.

Professor Gill said: “Science is a shared endeavour in society and communicating with the public is crucial to agreeing future research directions. In my research, using gene technologies, responsible public engagement builds trust and transparency. The Royal Society pairing scheme is a fantastic opportunity to see this in action.”

Senior policy advisor Tony Whitney will get hands on experience of Professor Gill’s work, which includes developing gene therapy for lung conditions such as cystic fibrosis, in a reciprocal visit next year. Researchers at the University of Oxford’s Radcliffe Department of Medicine also hope to learn more about engaging the public with their work during his visit.

The Royal Society’s pairing scheme, which started in 2001, aims to build bridges between parliamentarians, civil servants and some of the best scientists in the UK.

 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.